Rocket Lab (RKLB) on Solana

Raymond James analyst Brian Gesuale reiterated a Buy rating on Rocket Lab (RKLB) with an $80 price target, naming it one of three stocks top Wall Street analysts consider attractive long-term investments. Gesuale's thesis centers on vertical integration and the Iridium acquisition, which he says will deliver approximately $500 million in EBITDA and $300 million in free cash flow, making Rocket Lab the only vertically integrated space company with positive free cash flow. The company's backlog has more than doubled to roughly $2.4 billion from $1.1 billion in Q3 2025.

Gesuale sees Rocket Lab shifting from a heavy-investment phase into monetization, forecasting 59% revenue growth for 2026 alongside improving gross margins and meaningfully lower R&D expenditures. The analyst holds a 63% success rate and is ranked 369th among analysts tracked by TipRanks.

Rocket Lab completed two notable hardware milestones for its Neutron medium-lift rocket this week. The company's reusable "Hungry Hippo" fairing system—a design that keeps both fairing halves attached to the first stage so they open to release payload and then close to return with the booster—finished pre-flight testing at its Assembly and Integration Complex in Virginia. In parallel, a 10-meter test stand for Neutron's second stage was installed at Launch Complex 3. Upcoming steps include direct thrust-module testing on the launch mount, full-vehicle pad tests, a wet dress rehearsal, and a first-stage static fire.

The hardware progress comes as Rocket Lab builds a commercial launch book for Neutron: a confidential customer has reserved five missions through 2029, Kepler Communications holds a dedicated launch slot no earlier than 2028, and the vehicle is attached to a $397 million Space Force contract. The program has slipped from an original 2024 target, and CEO Peter Beck acknowledged this week that "the window for an end-of-year launch is narrowing" for the current Q4 2026 goal. RKLB shares rose more than 6% on Thursday to close at $67.82, putting the stock on track for its best weekly performance in over a month.

Rocket Lab's proposed $8.1 billion acquisition of Iridium cleared its first regulatory hurdle after the FCC accepted the license-transfer applications for filing, opening a public comment period that runs through November 9, 2026. The Iridium shareholder vote is scheduled for September 24, with deal closing expected in mid-2027. Under the deal terms, Iridium shareholders receive $27 cash plus 0.24–0.40 Rocket Lab shares per share depending on RKLB's stock price, implying roughly 5% ownership of the combined company. Rocket Lab has already secured the acquisition financing, having raised $1.94 billion through a share offering and terminated a $3.6 billion bridge facility.

On the technology front, Rocket Lab unveiled its Inverted Metamorphic Apex (IMM Apex) solar cell, achieving 31.5% beginning-of-life efficiency while cutting mass by 40% versus conventional cells by eliminating the germanium substrate. The company says it can manufacture the cells at multi-100-kilowatt volumes. Space Capital, an early Rocket Lab backer, publicly highlighted the development. RKLB shares were up about 1% on the week, tracking toward their first weekly gain in six weeks.

An analyst forecast projects Rocket Lab's core operations could exceed $1.5 billion in revenue during 2027 — entirely excluding any contribution from its pending $8 billion Iridium acquisition, which is targeted to close in mid-2027. The projection is grounded in the company's current trajectory: Q2 2026 revenue came in at $234 million (62% year-over-year growth), with Q3 2026 guidance set at $250–$265 million and full-year 2026 tracking toward roughly $970 million. Reaching the $1.5 billion threshold would require approximately 55% year-over-year growth from 2026 to 2027 — a pace the analyst describes as a slowdown relative to recent performance.

Supporting the outlook, Rocket Lab reported a record $2.36 billion backlog as of Q2 2026, with around 45% (~$1.1 billion) expected to convert to revenue within 12 months. Iridium's standalone 2025 revenue was approximately $872 million, meaning the combined entity could be on a run rate well above $2 billion annually by late 2027 if both trajectories hold.

Rocket Lab has secured the full financing required for its $8 billion acquisition of Iridium, completing a $1.944 billion at-the-market equity offering that issued 29.3 million shares. Combined with Iridium's existing $1.775 billion term loan facility — amended to remove change-of-control triggers — and available unrestricted cash, the capital stack covers the cash consideration, debt repayment, and transaction costs. The company also terminated its $3.6 billion senior secured bridge facility commitment, replacing short-term bridge financing with permanent, lower-cost debt backed by Iridium's free cash flow.

The deal, structured as a cash-and-stock transaction, cleared several major regulatory milestones ahead of its expected mid-2027 close, including HSR antitrust approval and SEC Form S-4 effectiveness on August 26, 2026. FCC applications remain pending. Completing the ATM removes a key financing overhang and signals Rocket Lab's confidence in executing one of the largest acquisitions in commercial space history, adding Iridium's satellite-communications infrastructure to its launch and spacecraft businesses.

Rocket Lab filed a formal protest with the Government Accountability Office on September 11, 2026, challenging NASA's decision to award Blue Origin a $700 million contract to build, launch, and operate the Mars Telecommunications Network (MTN) orbiter. The spacecraft is required to be delivered by December 31, 2028, and is expected to reach operational status at Mars by 2030, replacing two aging relay orbiters dating to 2001 and 2005. Rocket Lab contends that NASA's award decision "appears to be inconsistent with the eligibility criteria mandated by Congress" and that the agency's technical review of its own proposal contained "incorrect assertions and conclusions."

The protest marks a direct escalation from the initial contract loss disclosed in early September, when Rocket Lab missed out on the award and its stock slipped on the news. In its statement, Rocket Lab argued that "procurement standards exist to ensure fair competition and protect public investment" and that it is pursuing the review to uphold those standards for critical infrastructure. The outcome of a GAO bid protest typically takes up to 100 days; Blue Origin faced a similar situation in 2021 when it filed a GAO protest after losing NASA's lunar lander contract to SpaceX — a protest that was ultimately denied.

Rocket Lab successfully completed its 16th Electron mission of 2026 on September 11, lifting off from Launch Complex 1 in New Zealand at 3:28 p.m. NZST. Designated "Happily Ever Faster," the mission delivered a single Earth observation satellite for a confidential customer into a 500 km circular low Earth orbit and marked the company's 95th Electron launch overall.

The milestone reinforces Rocket Lab's claim as the world's leading small launch provider, with the company citing schedule certainty and dedicated orbital access as key differentiators amid broader industry strain on launch availability. A 17th Electron mission is already slated for later in September, sustaining the high-cadence pace that has defined the RKLB commercial launch story in 2026.

Rocket Lab completed its 94th Electron mission on September 3, deploying Synspective's StriX synthetic aperture radar satellite — the "Owl Around The World" mission — to a 575-kilometer low-Earth orbit from its Mahia, New Zealand launch complex. The launch was Rocket Lab's 15th of 2026 and marked the 11th consecutive successful mission for Synspective, which uses the radar-imaging constellation to capture ground imagery regardless of weather or lighting conditions. The flight came after two weather delays caused by strong winds earlier in the week.

RKLB shares gained 1% on Wednesday to close at $63.10, snapping a three-session losing streak, even as CFO Adam Spice disclosed plans to sell approximately 140,000 shares worth $8.77 million under a pre-arranged Rule 10b5-1 plan — on top of a separate $4.45 million sale in August. Investors appeared unfazed by the insider activity given the scale of Rocket Lab's contracted backlog: Synspective alone has 16 additional dedicated Electron missions booked through 2030 with 17 more added in June, while customer iQPS holds nine additional launches scheduled through the same period, underscoring the long-runway visibility behind the company's launch cadence.

Blue Origin was awarded a $700 million NASA contract to build, launch, and operate a Mars Telecommunications Network orbiter — a prize Rocket Lab had competed for with a proposal built around its Explorer spacecraft platform and optical communications technology. CEO Peter Beck cited the company's track record: "There's very few folks that can demonstrate the level of capability and experience that we have." Retail investors and online commentary attributed the loss in part to ongoing Neutron delays, with Beck himself acknowledging that "the window for an end-of-year launch is narrowing" as the vehicle still requires integrated testing, a wet dress rehearsal, and a first-stage static fire before it can fly.

RKLB shares fell roughly 2% on the news, marking the ninth decline in ten sessions, though the stock remains up about 29% over the past year. ARK Investment Management moved in the opposite direction, purchasing approximately 705,000 shares across two days for a combined outlay of around $44 million — a notable expression of conviction from Cathie Wood's fund even as the NASA setback and Neutron timeline uncertainty weigh on near-term sentiment.

Rocket Lab pushed its "Owl Around The World" Electron mission — originally scheduled for August 31 — to no earlier than September 1, 2026, citing strong winds forecast over Launch Complex 1 in New Zealand. The flight, which would deploy Synspective's StriX satellite, is set to become the company's 94th Electron mission and 15th launch of 2026 once it gets off the ground, with a new window opening at 7:30 a.m. ET.

Separately, two insiders sold a combined $2.8 million worth of RKLB shares on August 29. Chief Operating Officer Frank Klein disposed of 35,558 shares at $66.25–$67.54 per share (~$2.37M), while General Counsel Arjun Kampani sold 6,034 shares at $66.50–$67.16 (~$402K). Both transactions were executed automatically under Rule 10b5-1 trading plans adopted in September 2025, meaning they were pre-scheduled rather than discretionary. Klein retained roughly 925,737 shares and Kampani kept 250,917 shares after the sales. RKLB slipped nearly 1% overnight on the combined news, extending its third consecutive weekly decline, though the stock remains up approximately 34% over the past month.